Childhood leprosy in Essimbiland of Cameroon: results of chart review and school survey.
BACKGROUND
The WHO targeted to eliminate leprosy from the world as a public health problem by reducing the prevalence to less than 1 case per 10000 population based on the use of multi-drug therapy (MDT). Despite the success of MDT, endemic pools still exist in some countries that have attained the national elimination threshold.


OBJECTIVE
Assess the burden of childhood leprosy and control efforts in Essimbiland of Cameroon.


METHODS
The records of children patients were reviewed in two main primary health care institutions and 4 primary schools in Essimbiland having 459 pupils were surveyed for leprosy. A purposive sampling of all available registers and pupils was used.


RESULTS
A total of 1129 case files were reviewed covering the periods before MDT (1961-1967) implementation in 1982 and post MDT (1982-1999); no records were available from 1968-1991. From chart review, 42 (23.3%) new leprosy cases from 1961-1967 and 35 (12.2%) from 1982-1998 were from the Mbingo leprosarium. 31 (39.7%) of 78 childhood leprosy cases from chart review [1961-1967 and 1982-1999] were from Essimbiland. Of the 35 incident childhood leprosy cases from 1982-1998, 24 (68.6%) were from Essimbiland compared to other divisions. Poor record - keeping on leprosy was common in the study area. Among 459 pupils surveyed in 4 primary schools, 6 (1.3%) new leprosy cases were identified giving a prevalence of 131 per 10,000 pupils. The common skin lesion was on the back but one pupil had both hands clawed. 16 (3.5%) pupils were placed on observation. All the new leprosy cases from the school survey were indigenes of Essimbiland.


CONCLUSIONS
Childhood leprosy is a public health problem in the Essimbiland requiring school surveys and a house-to-house search for new cases.
Nsagha
D S
DS
Department of Public Health and Hygiene, Medicine Programme, Faculty of Health Sciences, University of Buea, P.O.Box 63, Buea, Cameroon. dsnsagha@gmail.com
Bamgboye
E A
EA
Oyediran
A B O
AB
D000293:Adolescent; D017677:Age Distribution; D002163:Cameroon / Q000453:epidemiology; D002648:Child; D005260:Female; D006306:Health Surveys; D006801:Humans; D015994:Incidence; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000145:classification / Q000188:drug therapy* / Q000453:epidemiology*; D008297:Male; D008499:Medical Records; D017678:Sex Distribution; D016896:Treatment Outcome; D014944:World Health Organization
D007917:Leprostatic Agents